Download Stanford Profiles: /viewBiosketch

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Peter B. Gregory, M.D Professor of Medicine, Emeritus
Education
1959 B.A.
1963 M.D.
1963-64
1966-67
1967-68
1968-69
1969-70
1970-71
(Chemistry) Yale University, New Haven, Connecticut
cum laude, Yale School of Medicine, New Haven,Connecticut
Internship (Medicine), Grace New Haven Community Hospital
First Year Resident (Medicine), Yale New Haven Medical Center
Senior Resident (Medicine), Stanford Medical Center, Stanford, CA.
Chief Resident (Medicine), Stanford Medical Center, Stanford, CA.
Fellow (Liver), Yale University Hospital, New Haven, Conn.
Fellow (Gastroenterology), Stanford Medical Center, Stanford, CA.
Research and Professional Experience
1962
The Ramsey Memorial Scholarship Prize (Yale School of Medicine)
1963
The Parker Prize (Yale School of Medicine)
1962-63
A.O.A.
1964-66
Research Associate, Atomic Bomb Casualty Commission,
Hiroshima, Japan (USPHS)
1971-72
Instructor of Medicine, Stanford University School of Medicine,
Stanford, California
1972-77
Academic Career Development Award, NIAMD-USPHS AM 70318
1972-78
Assistant Professor of Medicine, Stanford University School of
Medicine, Stanford, California
1978-83
Associate Professor of Clinical Medicine, Stanford University
School of Medicine, Stanford, California
1979-87
Section Chief, Gastroenterology, VAMC, Palo Alto, California
1983-02
Professor of Medicine (Clinical), Stanford University School of
Medicine, Stanford, California.
1987-89
Associate Dean for Graduate Medical Education, Stanford
University School of Medicine, Stanford, California.
1990-97
Associate Dean for Clinical Affairs, Medical Director, Faculty Practice
Program
1994-97
Chief Medical Officer, Stanford Health Services
1997-01
Senior Associate Dean for Clinical Affairs
1999-01
Chief Medical Officer, Stanford Hospital and Clinics
2002Professor of Medicine (Clinical), Emeritus, Stanford University School of
Medicine, Stanford, California.
PUBLICATIONS (selected)
Gregory PB, Knauer CM, Kempson RL, and Miller R. Steroid therapy in severe
viral hepatitis: A double-blind, randomized trial of methylprednisolone versus
placebo. N.E.J.M. 294;681-686, 1976.
Gregory PB, Broekelschen PH, Hill MD, Lipton AB, Knauer CM, Egger M,
Miller R. The complications of diuresis in the alcoholic patient with ascites: A
controlled trial. Gastroenterology 73;534-538, 1977.
Gregory PB, Knauer CM, Fogel MR, Andres LL, Rinki MM, Walker JE. Upper
gastrointestinal bleeding: Accuracy of clinical diagnosis and prognosis.
Digestive Diseases and Sciences 26:65s-69s, 1981.
Fogel MR, Knauer CM, Andres LL, Mahal AS, Stein DET, Kemeny MJ, Rinki
MM, Walker JE, Siegmund D, Gregory PB. Continuous intravenous vasopressin
in active upper gastrointestinal bleeding: A placebo-controlled trial. Annals of
Internal Medicine 96:565-569, l982.
Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, Robinson
WS, Merigan TC, Gregory PB. Survival in chronic hepatitis B: an analysis of
three hundred seventy-nine patients. Annals of Internal Medicine 101:613616, 1984.
Garcia G, Smith CI, Weissberg JI, Eisenberg M, Bissett J, Nair PV, Mastre B,
Rosno S, Roskamp D, Waterman K, Pollard RB, Tong MJ, Brown BW, Robinson
WS, Gregory PB, Merigan TC. Adenine arabinoside monophosphate
(vidarabine phosphate) in combination with human leukocyte interferon in the
treatment of chronic hepatitis B: A randomized, double-blind, placebo-controlled
trial. Annals of Internal Medicine, 107:278-285, 1987.
Bissett J, Eisenberg M, Gregory P, Robinson WS, Merigan TC. Recombinant
Fibroblast Interferon and Immune Interferon for Treating Chronic Hepatitis B
Virus Infection: Patients' Tolerance and the Effect on Viral Markers.
The Journal of Infectious Diseases, 157:1076-80, 1988
Gregory P and the Veterans Affairs Cooperative Variceal Sclerotherapy Group.
Prophylactic Sclerotherapy for Esophageal Varices in Men with Alcoholic Liver
Disease: A Randomized, Single-blind, Multicenter Clinical Trial. New England
Journal of Medicine 324:1779-84, 1991
Kearns PJ, Young H, Garcia G, Blaschke T, O'Hanlon G, Rinki M, Sucher K,
Gregory P. Accelerated Improvement of Alcoholic Liver Disease with Enteral
Nutrition. Gastroenterology ,102:200-05, 1992
Gregory P and the Veterans Affairs Cooperative Variceal Sclerotherapy Group.
Sclerotherapy for Male Alcoholic Cirrhotic Patients who have bled from
esophageal varices: Results of a Randomized, Multicenter Clinical Trial.
Hepatology 20:618-25, 1994)
(1) Currently Active Support
None
Related documents